Semaglutide

GLP-1 receptor agonist analogue

Semaglutide is a long-acting GLP-1 receptor agonist analogue used globally as a reference in metabolic and incretin research. Supplied in 5 mg and 10 mg fills with a complete identity and purity dossier at ≥ 99.2% HPLC purity.

≥ 99.2% HPLC purity with full dossier
High-resolution MS + AAA identity proof
cGMP synthesis, sterile fill
The benchmark GLP-1 research reference

Choisir le format

70 $US1

96 vials of 5 mg in current lot · ships in 24 h cold-chain

Forme	Lyophilized powder · 3 mL amber vial
Contenu net	5 mg
Formats disponibles	5 mg · 10 mg
CAS	910463-68-2
Masse molaire	4113.6 g/mol
Purity (HPLC)	≥ 99.2%
Conservation	Store at –20 °C. Cold-chain shipment included.

Depuis le laboratoire

Notes de recherche

Background reading on the analysis behind Semaglutide’s certificate.

Analytics

Semaglutide vs. Tirzepatide: Comparing Mono-GLP-1 and Dual GLP-1/GIP Agonism in Laboratory Models

A technical comparison of Semaglutide vs. Tirzepatide in research models. Explore receptor kinetics, structural biochemistry, and laboratory reconstitution data.

22 January 20265 min de lecture Quality

How to read a peptide certificate of analysis

Purity, identity, endotoxin, residual solvents — what each number on a peptide COA actually proves, and the four fields to check before you trust it.

6 January 20264 min de lecture Reference

The five research categories, and what distinguishes them

Recovery, growth, metabolic, longevity and tanning — how the catalogue is organised, which receptor families each category maps to, and where the overlaps are.

6 November 20252 min de lecture

Associé à